Fanconi Anemia Complementation Group Proteins

"Fanconi Anemia Complementation Group Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A diverse group of proteins whose genetic MUTATIONS have been associated with the chromosomal instability syndrome FANCONI ANEMIA. Many of these proteins play important roles in protecting CELLS against OXIDATIVE STRESS.

Descriptor ID	D051856
MeSH Number(s)	D12.776.313
Concept/Terms	Fanconi Anemia Complementation Group Proteins Fanconi Anemia Complementation Group Proteins FANC Proteins Fanconi Anemia Proteins

Below are MeSH descriptors whose meaning is more general than "Fanconi Anemia Complementation Group Proteins".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Fanconi Anemia Complementation Group Proteins [D12.776.313]

Below are MeSH descriptors whose meaning is related to "Fanconi Anemia Complementation Group Proteins".

Below are MeSH descriptors whose meaning is more specific than "Fanconi Anemia Complementation Group Proteins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Fanconi Anemia Complementation Group Proteins" by people in this website by year, and whether "Fanconi Anemia Complementation Group Proteins" was a major or minor topic of these publications.

Bar chart showing 9 publications over 7 distinct years, with a maximum of 2 publications in 2007 and 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	0	1	1
2006	1	0	1
2007	2	0	2
2011	1	1	2
2017	1	0	1
2018	1	0	1
2021	1	0	1

Below are the most recent publications written about "Fanconi Anemia Complementation Group Proteins" by people in Profiles.

Zhan S, Siu J, Wang Z, Yu H, Bezabeh T, Deng Y, Du W, Fei P. Focal Point of Fanconi Anemia Signaling. Int J Mol Sci. 2021 Nov 30; 22(23).

View in: PubMed
Ma C, Nepal M, Kim JH, Fan P, Fei P. A new look at molecular biology of breast cancer. Cancer Biol Ther. 2019; 20(1):1-5.

View in: PubMed
Nepal M, Che R, Zhang J, Ma C, Fei P. Fanconi Anemia Signaling and Cancer. Trends Cancer. 2017 12; 3(12):840-856.

View in: PubMed
Kao WH, Riker AI, Kushwaha DS, Ng K, Enkemann SA, Jove R, Buettner R, Zinn PO, S?nchez NP, Villa JL, D'Andrea AD, S?nchez JL, Kennedy RD, Chen CC, Matta JL. Upregulation of Fanconi anemia DNA repair genes in melanoma compared with non-melanoma skin cancer. J Invest Dermatol. 2011 Oct; 131(10):2139-42.

View in: PubMed
Suhasini AN, Rawtani NA, Wu Y, Sommers JA, Sharma S, Mosedale G, North PS, Cantor SB, Hickson ID, Brosh RM. Interaction between the helicases genetically linked to Fanconi anemia group J and Bloom's syndrome. EMBO J. 2011 Feb 16; 30(4):692-705.

View in: PubMed
Gupta R, Sharma S, Sommers JA, Kenny MK, Cantor SB, Brosh RM. FANCJ (BACH1) helicase forms DNA damage inducible foci with replication protein A and interacts physically and functionally with the single-stranded DNA-binding protein. Blood. 2007 Oct 01; 110(7):2390-8.

View in: PubMed
Peng M, Litman R, Xie J, Sharma S, Brosh RM, Cantor SB. The FANCJ/MutLalpha interaction is required for correction of the cross-link response in FA-J cells. EMBO J. 2007 Jul 11; 26(13):3238-49.

View in: PubMed
Gupta R, Sharma S, Doherty KM, Sommers JA, Cantor SB, Brosh RM. Inhibition of BACH1 (FANCJ) helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strand. Nucleic Acids Res. 2006; 34(22):6673-83.

View in: PubMed
Gupta R, Sharma S, Sommers JA, Jin Z, Cantor SB, Brosh RM. Analysis of the DNA substrate specificity of the human BACH1 helicase associated with breast cancer. J Biol Chem. 2005 Jul 08; 280(27):25450-60.

View in: PubMed

People

Explore

Similar Concepts

Top Journals